期刊文献+

电话指导骨关节炎患者自我管理的随访观察 被引量:6

Telephone guide self-management of osteoarthritis patients
下载PDF
导出
摘要 目的探讨电话指导自我管理对改善骨关节炎患者疗效的影响。方法 172骨关节炎患者随机分为电话指导管理组、健康教育组和常规治疗组,VAS标准评估所有患者基线和12月后20 m步行痛、关节触痛、WOMAC骨关节炎指数。结果在12月后电话指导组、健康教育组和常规治疗组三组患者20 m步行痛程度、关节触痛、WOMAC(VAS法)均较基线时有明显改善(P<0.05)。12月后电话指导组的20 m步行痛程度、关节触痛、WOMAC(VAS)均较常规治疗组有明显改善(P<0.05)。与健康教育组和常规治疗组比较,电话指导管理组患者依从性明显升高,差异有统计学意义(P<0.05)。结论电话指导骨关节炎患者自我管理,提高了患者的依从性及临床疗效。 Objective To investigate the phone guide self-management to improve the therapeutic effect in patients with osteoarthritis.Methods A hundred and ninety-two patients with osteoarthritis were randomly divided into the phone guide self management group,health education group and conventional treatment group.VAS standard evaluation was made of all patients at baseline and after 12 weeks of 20m walking pain,joint tenderness,WOMAC osteoarthritis index.Results 12 months after in the phone guide self-management group,20 m walk,joint tenderness,WOMAC(VAS) of patients improved significantly when compared with baseline(P0.05).Compared with the other two groups,patients in the phone guide self-management group had higher compliance,which has a significant difference.Conclusion Telephone guide self-management can improve the efficacy in patients with osteoarthritis.
出处 《安徽医药》 CAS 2012年第5期639-641,共3页 Anhui Medical and Pharmaceutical Journal
关键词 骨关节炎 电话指导 自我管理 osteoarthritis telephone guidance self-management
  • 相关文献

参考文献9

二级参考文献23

  • 1刘承统,黄开合,谢林,刘晓东.醋氯芬酸缓释片在犬体内药代动力学及其相对生物利用度研究[J].中国药科大学学报,2004,35(5):443-445. 被引量:4
  • 2徐洪港,徐斌,冯瑛琦.膝关节骨性关节炎的关节镜治疗[J].安徽医药,2006,10(1):38-39. 被引量:4
  • 3Altman R, Asch E, Bloeh D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee [ J ], Arthritis Rheum, 1986,29 (8) : 1039 - 49.
  • 4Cryer B, Fetdman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivior of widely used non-steroidal anti-inflammatory drugs [ J ]. Am J Med, 1998,104:413 - 21.
  • 5Van Ryn J, Pairet M. Selective cyclooxygenase-2 inhibitors : pharmacology, clinical effects and therapeutic potential [ J ]. Exp Opin Invest Drugs,1997,6:609 - 14.
  • 6Legrand E. Aceclofenac in the management of inflammatory pain [ J ]. Expert Opin Pharmacother,2004,5 ( 6 ) : 1347 - 57.
  • 7Schattenkirchner M, Milachowski KA. A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain [ J ]. Clin Rheumatol,2003,22 (2) : 127 - 35.
  • 8Brogden RN, Wiseman LR. Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management [ J ]. Drugs, 1996,52 ( 1 ) : 113 -24.
  • 9Ouedraogo DD,Seogo H,Cisse R,et al.Risk factors associated with osteoarthritis of the knee in a rheumatology outpatient clinic in Ouagadougou[J].Burkina Faso,2008,68(6):597-9.
  • 10Bellamy N,Buchanan WW,Goldsmith CH,et al.Validation study of WOMAC:a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee[J].J Rheumatol,1988,15:1833-40.

共引文献1383

同被引文献84

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部